Thalassemia
Showing NaN - NaN of 10
A Long-term Follow-up Study in Subjects Who Received CTX001
Enrolling by invitation
- Beta-Thalassemia
- +6 more
- CTX001
-
New York, New York
- +12 more
Nov 18, 2022
Red Blood Cell - IMProving trAnsfusions for Chronically
Recruiting
- Sickle Cell Disease
- +2 more
- Red Blood Cell (RBC) Transfusion
-
Oakland, California
- +13 more
Mar 18, 2022
Sickle Cell Disease, Thalassemia Trial in New York (Transfusion, Blood, Chelation therapy)
Terminated
- Sickle Cell Disease
- Thalassemia
- Transfusion
- +2 more
-
New York, New YorkColumbia University Medical Center
Aug 11, 2016
Hepatitis C, Thalassemia Trial in Canada, United Kingdom, United States (Peginterferon Alfa-2a and Ribavirin, Ribavirin)
Completed
- Hepatitis C
- Thalassemia
- Peginterferon Alfa-2a and Ribavirin
- Ribavirin
-
Oakland, California
- +4 more
Mar 3, 2014
People With Thalassemia: The Thalassemia Longitudinal Cohort
Completed
- Thalassemia
-
Los Angeles, California
- +13 more
Nov 9, 2011
Thalassemia Trial in New York (Deferoxamine, Deferasirox)
Unknown status
- Thalassemia
-
New York, New YorkWeill Cornell Medical Center
Nov 4, 2010
Iron Overload, Thalassemia Trial in New York (Combination Iron Chelation Therapy)
Completed
- Iron Overload
- Thalassemia
- Combination Iron Chelation Therapy
-
New York, New YorkCornell University Medical College
Jan 12, 2010